% T Cells (CD3+) Test

The % T Cells biomarker tells you what fraction of your lymphocytes, a type of white blood cell, are T cells. T cells are essential for a healthy immune system. They identify infected, cancerous, or abnormal cells and either help destroy them directly or activate other immune cells to do the job.

All T cells are marked by a surface protein called CD3, so the term CD3+ T cells refers to the entire population of T cells in your blood. Measuring the percentage of CD3+ T cells gives a sense of how robust or depleted your T cell population is relative to your overall lymphocyte count.

T cells come in different forms:

• CD4+ helper T cells coordinate the immune response and help activate B cells (which make antibodies) and CD8+ cells.
• CD8+ cytotoxic T cells directly kill infected or cancerous cells.
• Double-negative (CD4-CD8-) T cells and CD3+CD20+ T cells are rarer subsets that play regulatory or inflammatory roles, and are being actively studied in autoimmunity, cancer, and immunotherapy.

When your % T Cells is low, it may suggest an issue with immune function, such as:

• Ongoing infection (like HIV, which targets CD4+ T cells)
• Immune suppression from chemotherapy, steroids, or certain medications
• A primary immune deficiency or bone marrow disorder

When your % T Cells is high, it often reflects a shift in the immune system due to:

• Viral infection (your body may be ramping up T cell activity)
• Recovery from immunosuppression
• Certain autoimmune conditions or T cell-driven lymphomas (in rare cases)

It’s important to interpret this percentage in context. A normal or even high percentage of T cells doesn’t always mean your immune system is functioning perfectly. For example, if your total lymphocyte count is low, a normal-looking percentage might still reflect a low absolute number of T cells. That’s why % T Cells is often evaluated alongside absolute T cell count, CD4/CD8 ratios, and other immune markers.

This biomarker is especially useful in:

• Monitoring immunodeficiency disorders
• Evaluating responses to infection, cancer, or immunotherapy
• Tracking immune recovery after treatments like bone marrow transplants or antiretroviral therapy